Ph-negative and bcr-negative atypical chronic myelogenous leukemia

biological features and clinical outcome

E. Montefusco, G. Alimena, F. Lo Coco, M. R. De Cuia, Y. Z. Wang, M. A Aloe Spiriti, F. Mancini, M. Cedrone, M. Mancini, F. Mandelli

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

We report the clinical, hematologic, cytogenetic, and molecular charateristics of 13 patients with Philadelphia-negative (Ph-), bcr-negative atypical chronic myelogenous leukemia (CML). In the majority of cases, the phenotypic features at presentation resembled those of typical CML. However, these patients presented with a higher median age, lower median hemoglobin levels, and lower leukocyte and platelet counts than patients with Ph-positive CML. Cytogenetic analysis showed an abnormal karyotype in only one case. Southern blot investigation, using probes exploring the entire M-bcr region, demonstrated the absence of genomic bcr-abl rearrangements. The assessment of clonality in five patients (study of X-methylation patterns in females heterozygous at the DXS255 locus) indicated the proliferation of a monoclonal cell population. Disease evolution was mostly characterized by bone marrow failure, extramedullary infiltrates, and poor response to chemotherapy, without evidence of overt acute transformation. Our observations suggest that some hematologic and clinical features and the modalities of disease progression are presently the most helpful factors in distinguising these bcr/ abl-negative patients from those with typical bcr + CML. The differences existing also with chronic myelomonocytic leukemia (CMMoL), allow the consideration of ph-/bcr- CML as a separate entity, the nature of which remains to be elucidated.

Original languageEnglish
Pages (from-to)17-21
Number of pages5
JournalAnnals of Hematology
Volume65
Issue number1
DOIs
Publication statusPublished - Jul 1992

Fingerprint

Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Leukemia, Myelomonocytic, Chronic
Abnormal Karyotype
Cytogenetic Analysis
Southern Blotting
Platelet Count
Leukocyte Count
Cytogenetics
Methylation
Disease Progression
Hemoglobins
Bone Marrow
Drug Therapy
Population

Keywords

  • bcr-negative CML
  • Chronic myelomonocytic leukemia
  • Philadelphia-negative CML

ASJC Scopus subject areas

  • Hematology

Cite this

Montefusco, E., Alimena, G., Coco, F. L., De Cuia, M. R., Wang, Y. Z., Spiriti, M. A. A., ... Mandelli, F. (1992). Ph-negative and bcr-negative atypical chronic myelogenous leukemia: biological features and clinical outcome. Annals of Hematology, 65(1), 17-21. https://doi.org/10.1007/BF01715120

Ph-negative and bcr-negative atypical chronic myelogenous leukemia : biological features and clinical outcome. / Montefusco, E.; Alimena, G.; Coco, F. Lo; De Cuia, M. R.; Wang, Y. Z.; Spiriti, M. A Aloe; Mancini, F.; Cedrone, M.; Mancini, M.; Mandelli, F.

In: Annals of Hematology, Vol. 65, No. 1, 07.1992, p. 17-21.

Research output: Contribution to journalArticle

Montefusco, E, Alimena, G, Coco, FL, De Cuia, MR, Wang, YZ, Spiriti, MAA, Mancini, F, Cedrone, M, Mancini, M & Mandelli, F 1992, 'Ph-negative and bcr-negative atypical chronic myelogenous leukemia: biological features and clinical outcome', Annals of Hematology, vol. 65, no. 1, pp. 17-21. https://doi.org/10.1007/BF01715120
Montefusco, E. ; Alimena, G. ; Coco, F. Lo ; De Cuia, M. R. ; Wang, Y. Z. ; Spiriti, M. A Aloe ; Mancini, F. ; Cedrone, M. ; Mancini, M. ; Mandelli, F. / Ph-negative and bcr-negative atypical chronic myelogenous leukemia : biological features and clinical outcome. In: Annals of Hematology. 1992 ; Vol. 65, No. 1. pp. 17-21.
@article{19a991ce12ec49299d6210dc05ff990b,
title = "Ph-negative and bcr-negative atypical chronic myelogenous leukemia: biological features and clinical outcome",
abstract = "We report the clinical, hematologic, cytogenetic, and molecular charateristics of 13 patients with Philadelphia-negative (Ph-), bcr-negative atypical chronic myelogenous leukemia (CML). In the majority of cases, the phenotypic features at presentation resembled those of typical CML. However, these patients presented with a higher median age, lower median hemoglobin levels, and lower leukocyte and platelet counts than patients with Ph-positive CML. Cytogenetic analysis showed an abnormal karyotype in only one case. Southern blot investigation, using probes exploring the entire M-bcr region, demonstrated the absence of genomic bcr-abl rearrangements. The assessment of clonality in five patients (study of X-methylation patterns in females heterozygous at the DXS255 locus) indicated the proliferation of a monoclonal cell population. Disease evolution was mostly characterized by bone marrow failure, extramedullary infiltrates, and poor response to chemotherapy, without evidence of overt acute transformation. Our observations suggest that some hematologic and clinical features and the modalities of disease progression are presently the most helpful factors in distinguising these bcr/ abl-negative patients from those with typical bcr + CML. The differences existing also with chronic myelomonocytic leukemia (CMMoL), allow the consideration of ph-/bcr- CML as a separate entity, the nature of which remains to be elucidated.",
keywords = "bcr-negative CML, Chronic myelomonocytic leukemia, Philadelphia-negative CML",
author = "E. Montefusco and G. Alimena and Coco, {F. Lo} and {De Cuia}, {M. R.} and Wang, {Y. Z.} and Spiriti, {M. A Aloe} and F. Mancini and M. Cedrone and M. Mancini and F. Mandelli",
year = "1992",
month = "7",
doi = "10.1007/BF01715120",
language = "English",
volume = "65",
pages = "17--21",
journal = "Annals of Hematology",
issn = "0939-5555",
publisher = "Springer Verlag",
number = "1",

}

TY - JOUR

T1 - Ph-negative and bcr-negative atypical chronic myelogenous leukemia

T2 - biological features and clinical outcome

AU - Montefusco, E.

AU - Alimena, G.

AU - Coco, F. Lo

AU - De Cuia, M. R.

AU - Wang, Y. Z.

AU - Spiriti, M. A Aloe

AU - Mancini, F.

AU - Cedrone, M.

AU - Mancini, M.

AU - Mandelli, F.

PY - 1992/7

Y1 - 1992/7

N2 - We report the clinical, hematologic, cytogenetic, and molecular charateristics of 13 patients with Philadelphia-negative (Ph-), bcr-negative atypical chronic myelogenous leukemia (CML). In the majority of cases, the phenotypic features at presentation resembled those of typical CML. However, these patients presented with a higher median age, lower median hemoglobin levels, and lower leukocyte and platelet counts than patients with Ph-positive CML. Cytogenetic analysis showed an abnormal karyotype in only one case. Southern blot investigation, using probes exploring the entire M-bcr region, demonstrated the absence of genomic bcr-abl rearrangements. The assessment of clonality in five patients (study of X-methylation patterns in females heterozygous at the DXS255 locus) indicated the proliferation of a monoclonal cell population. Disease evolution was mostly characterized by bone marrow failure, extramedullary infiltrates, and poor response to chemotherapy, without evidence of overt acute transformation. Our observations suggest that some hematologic and clinical features and the modalities of disease progression are presently the most helpful factors in distinguising these bcr/ abl-negative patients from those with typical bcr + CML. The differences existing also with chronic myelomonocytic leukemia (CMMoL), allow the consideration of ph-/bcr- CML as a separate entity, the nature of which remains to be elucidated.

AB - We report the clinical, hematologic, cytogenetic, and molecular charateristics of 13 patients with Philadelphia-negative (Ph-), bcr-negative atypical chronic myelogenous leukemia (CML). In the majority of cases, the phenotypic features at presentation resembled those of typical CML. However, these patients presented with a higher median age, lower median hemoglobin levels, and lower leukocyte and platelet counts than patients with Ph-positive CML. Cytogenetic analysis showed an abnormal karyotype in only one case. Southern blot investigation, using probes exploring the entire M-bcr region, demonstrated the absence of genomic bcr-abl rearrangements. The assessment of clonality in five patients (study of X-methylation patterns in females heterozygous at the DXS255 locus) indicated the proliferation of a monoclonal cell population. Disease evolution was mostly characterized by bone marrow failure, extramedullary infiltrates, and poor response to chemotherapy, without evidence of overt acute transformation. Our observations suggest that some hematologic and clinical features and the modalities of disease progression are presently the most helpful factors in distinguising these bcr/ abl-negative patients from those with typical bcr + CML. The differences existing also with chronic myelomonocytic leukemia (CMMoL), allow the consideration of ph-/bcr- CML as a separate entity, the nature of which remains to be elucidated.

KW - bcr-negative CML

KW - Chronic myelomonocytic leukemia

KW - Philadelphia-negative CML

UR - http://www.scopus.com/inward/record.url?scp=0026685099&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026685099&partnerID=8YFLogxK

U2 - 10.1007/BF01715120

DO - 10.1007/BF01715120

M3 - Article

VL - 65

SP - 17

EP - 21

JO - Annals of Hematology

JF - Annals of Hematology

SN - 0939-5555

IS - 1

ER -